Welcome to the DZIF -

the German Center for Infection Research

Information on SARS-CoV-2

Visit page

Research Areas

DZIF is doing research in nine areas:


News and Press Releases.

© Fusion Medical Animation
Alina Renz, Lina Widerspick und Andreas Dräger
© Uni Tübingen

SARS-CoV-2: Bioinformaticians discover a new weakness of the virus

The search for effective antiviral agents against the new coronavirus is in full swing. Using a novel approach, Tübingen bioinformaticians have now discovered a weakness in the virus that could be

New SARS-CoV-2 neutralizing antibody enters clinical phase

Cologne, Marburg, Braunschweig and Ingelheim, Germany, 18 December 2020 – Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research (DZIF) and Boehringer
Prof. Dr Stephan Urban
© Dominik Buschardt

Translational success for the DZIF: US pharma giant Gilead secures Hepcludex

Hepcludex (bulevirtide) is the first medication for the treatment of hepatitis D, a virus blocker whose development had been masterminded by DZIF Professor Dr Stephan Urban of Heidelberg University
Rolf Müller
© HZI/HIPS/ Foto: Oliver Dietze

Rolf Müller has been awarded the Leibniz Prize 2021

Professor Rolf Müller, Managing Director of the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has been awarded the Gottfried Wilhelm Leibniz Prize by the German Research Foundation

Up-to-date information and behaviour rules

Coronavirus info


Always up-to-date

Sign up for our quarterly newsletter and our press releases and stay up to date.

Select mailing lists

The DZIF Media Centre

The DZIF in Videos, Pictures and Print.

Pipetting aid
© Fabian Grein/DZIF
image jpeg (1.16 MB)

Pipetting aid

jpeg (1.16 MB)

Research in Focus

Our Partner Sites

Databases- & Biobanks 2019